Strategies to accelerate drug development through harmonization of early and late stage processes


Challenges with technical transferability, data consistency, and product performance predictability across different drug development stages can lead to unnecessary delays and escalating costs. This technical article presents a harmonized and streamlined approach established at Thermo Fisher Scientific for manufacturing AAV and LV vectors for discovery research using technologies and processes mirroring current GMP platforms.